You’ve more than likely heard of Ozempic, the diabetes drug hailed as a miracle weight-loss treatment. That drug is made by Danish healthcare giant Novo Nordisk. GLP-1 weight-loss and diabetes drugs have redefined what investors expect from healthcare in recent years. At eToro, we ran analysis
